Background illustration for clinical trials search

Paid Clinical Trials Denton

Discover 1,918 paid clinical trials in Denton, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of COYA 302 for the Treatment of ALS

for
Amyotrophic Lateral Sclerosis (ALS)
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Coya Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07161999

Phase2, Phase3, Recruiting

Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

for
Myasthenia Gravis
Location: Dallas TX, Cordova TN, New Orleans LA, O'Fallon IL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18 - 70+

Code: NCT07217587

Phase3, Recruiting

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

for
Atopic Dermatitis
Location: Arlington TX, Dallas TX, Fort Smith AR, Cypress TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06947993

Phase2, Recruiting

Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)

for
Degenerative Joint Disease of Shoulder
Location: Rockwall TX
Sponsor: North Texas Medical Research Institute, PLLC

Sex: All

Age: 30 - 70+

Code: NCT07125833

Recruiting

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

for
Cystic Fibrosis
Location: Dallas TX, Fort Worth TX, Oklahoma City OK, Houston TX,
Sponsor: Sonya Heltshe

Sex: All

Age: 0 - 10

Code: NCT04509050

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Fort Worth TX, Dallas TX, Houston TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: Arlington TX, Austin TX, Tulsa OK, Houston TX,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase3, Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

for
Atypical Teratoid/Rhabdoid Tumor,
Location: Dallas TX, Little Rock AR, Kansas City KS, St Louis MO,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 26

Code: NCT06465199

Phase1, Phase2, Recruiting

Recovery Through Inspiration, Support, and Empowerment

for
Suicidal Ideation, Suicide Attempt, Anxiety,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 27

Code: NCT07051200

Recruiting

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

for
Niemann-Pick Type C Disease, GM1 Gangliosidosis,
Location: Dallas TX, Rochester MN, Fairfax VA, Oakland CA,
Sponsor: Azafaros B.V.

Sex: All

Age: 4+

Code: NCT07054515

Phase3, Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

for
Type 1 Diabetes
Location: Dallas TX, Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: SAb Biotherapeutics, Inc.

Sex: All

Age: 5 - 40

Code: NCT07187531

Phase2, Recruiting
Featured

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations

for
Multiple Myeloma
Location: Dallas TX, Denver CO, Atlanta GA, Cincinnati OH,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06892522

Phase1, Phase2, Recruiting

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

for
Heart Failure, Cardiogenic Shock, Congenital Heart Disease,
Location: Dallas TX, Durham NC, New York NY, Palo Alto CA,
Sponsor: Stanford University

Sex: All

Age: 0 - 16

Code: NCT06080074

Phase2, Recruiting

MASA Valve Early Feasibility Study

for
Tetrology of Fallot, Pulmonary Stenosis, Truncus Arteriosus,
Location: Dallas TX, Peoria IL, Cincinnati OH, Philadelphia PA,
Sponsor: PECA Labs

Sex: All

Age: 0 - 22

Code: NCT05452720

Recruiting

Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies

for
Deep Venous Thrombosis
Location: Dallas TX, Oklahoma City OK, Austin TX, Little Rock AR,
Sponsor: Yale University

Sex: All

Age: 0 - 17

Code: NCT04924322

Phase2, Phase3, Recruiting

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

for
Neuroblastoma, Ewing Sarcoma, Osteosarcoma, Rhabdomyosarcoma,
Location: Dallas TX, Kansas City MO, St Louis MO, Birmingham AL,
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 30

Code: NCT06541262

Phase1, Phase2, Recruiting

Validation of Donor-Derived Cell-Free DNA (Dd-cfDNA) for Kidney Transplant Monitoring

for
Kidney Transplant Rejection, Cell-free DNA
Location: Dallas TX, Nashville TN, Jacksonville FL, Tampa FL,
Sponsor: Insight Molecular Diagnostics

Sex: All

Age: 18+

Code: NCT07060716

Recruiting

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

for
Chronic Pancreatitis, Exocrine Pancreas Carcinoma,
Location: Dallas TX, Houston TX, San Antonio TX, New Orleans LA,
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 0 - 17

Code: NCT06651580

Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

for
Leukemia, Juvenile Myelomonocytic, JMML, JCML,
Location: Dallas TX, Memphis TN, Kansas City MO, Denver CO,
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium

Sex: All

Age: 0 - 21

Code: NCT05849662

Phase1, Phase2, Recruiting

A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy

for
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD),
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Pierre Fabre Medicament

Sex: All

Age: 0+

Code: NCT03394365

Phase3, Recruiting